Brooksby to be new ABPI president

December 8, 2005
Sales and Marketing

Nigel Brooksby, Sanofi-Aventis UK's managing director has been named as the ABPI's next president.Brooksby will take over from the current …

Merck seeks US approval for cancer vaccine

December 7, 2005
Sales and Marketing

Merck has submitted its cervical cancer vaccine Gardasil to the FDA following impressive clinical trial results against the two most …

Can CSOs lead the way?

December 7, 2005
Sales and Marketing

With the spotlight shining on pharma sales teams, companies are exploring a variety of ways to improve productivity and effectiveness. …

Pharmacies offer lab tests for long-term conditions

December 7, 2005

Up to 6,000 patients could benefit from a new pilot project which will see high street pharmacies providing lab tests …

UK biotech signs $230 million deal with Genentech

December 7, 2005
Research and Development

UK biotech PIramed has signed a collaborative R&D deal with Genentech on a new class of cancer drugs, which could …

Research plans attract

December 7, 2005
Sales and Marketing

Plans to boost UK medical research through improvements to NHS systems is set to attract an extra £1 billion investment …

CIPR to debate impact of new prescribers

December 7, 2005

The CIPR Health & Medical Group will debate the new prescribing powers proposed for nurses and pharmacists at a special …

Rx Award wins for Paling Walters and LEC Advertising

December 7, 2005
Medical Communications

Paling Walters and Lane Earl & Cox won prestigious awards at New York's Rx Club Awards.The agency's Lethal obsession campaign …

Communicating with patients

December 5, 2005
Sales and Marketing

Despite little prospect of the restrictions in Europe on communicating directly with consumers being relaxed, the issue of DTC communications …

New UK headquarters for Bristol-Myers Squibb

December 5, 2005
Sales and Marketing BMS, UK

Bristol-Myers Squibb UK has moved into a new state-of-the-art head office in Uxbridge.The £5.5 million building houses over 200 employees, …

Merck plans diabetes compliance campaign

December 5, 2005
Medical Communications

Merck Pharmaceuticals has engaged Medicom to improve compliance in diabetic patients as part of the communications strategy for its type …

Sanofi-Aventis throws its weight behind Acomplia

December 5, 2005
Sales and Marketing

Sanofi-Aventis is gearing up for the launch of its potential blockbuster Acomplia, a drug which the company wants to promote …

Scheuble quits as Merck KGaA chief

December 5, 2005
Sales and Marketing

Bernhard Scheuble has stepped down as chief executive of German pharma company Merck KGaA, disagreements with the company's owners thought …

58,000 people living with HIV in the UK

December 5, 2005

The number of people living with HIV in the UK is now more than 58,000 – including nearly 20,000 who …

GlaxoSmithKline’s lapatinib hailed as latest ‘wonder drug’

December 1, 2005
Sales and Marketing

GlaxoSmithKline has released new data on a number of promising new drugs in its oncology pipeline – including breast cancer …

Altana and Serono seeking mergers

November 30, 2005
Sales and Marketing

Two of European pharma's mid-sized companies, Serono and Altana, have separately declared their openness to takeover talks, with Pfizer and …

Pfizer critical of generic plan for three million statin patients

November 30, 2005

More than three million extra patients could be prescribed statins in England and Wales in response to new guidance – …

Pfizer’s new anti-smoking drug shows promise

November 29, 2005
Sales and Marketing

Smokers taking a new Pfizer treatment are more likely to kick the habit compared to those using GlaxoSmithKline's Zyban, according …

Pharma unprepared for shift to secondary care

November 28, 2005
Research and Development

Nine out of ten European pharmaceutical companies believe they need to make significant changes to their businesses as a result …

AstraZeneca fights generic Nexium bid

November 25, 2005
Sales and Marketing

AstraZeneca has filed a lawsuit in the US courts to block the launch of a generic version of Nexium.The ulcer …

The Gateway to Local Adoption Series

Latest content